Network News

For his research on the development of rare malignant tumors in the hereditary DICER1 tumor predisposition syndrome, Dr. Felix Kommoss has been awarded the Rudolf Virchow Prize of the German Society of Pathology (Deutsche Gesellschaft für Pathologie, DGP) – the most prestigious research award in the field of pathology in Germany. Dr. Kommoss conducts research […]

Researchers from EMBL, LUMC, and collaborators reanalysed nearly 6,800 gut microbiome profiles, revealing a consistent microbial signature of colorectal cancer Summary Researchers have long suspected that the gut microbiome – the community of bacteria and other microorganisms living in the intestine – is closely linked to colorectal cancer. In a new study published in Cell Host […]

Scientists have shown how the edges of biological tissues create geometric constraints that help cells position themselves in a magnet-like manner, giving rise to structure and order inside developing embryos Summary One of the most striking biological transitions in nature happens early in development, when an embryo transforms from a simple ball of cells into […]

EMBL Grenoble researchers have developed unique instruments automating sample preparation and quality control for cryo-electron microscopy Summary Cryo-electron microscopy (cryo-EM) can help scientists determine the three-dimensional structure of proteins in unprecedented detail. Jacques Dubochet, former Group Leader at EMBL, shared the 2017 Nobel Prize in Chemistry with Joachim Frank and Richard Henderson for the development […]

Exclusive access to Samsung’s research platform enables protocol-aligned biosensor data capture, raw signal access, and end-to-end study execution, setting a new standard for wearable-based clinical evidence generation. Frankfurt, Germany, Jun. 24, 2026 — Samsung Electronics Co., Ltd., and Alcedis, a Huma company, the leading digital first CRO, announced at the 9th Annual Digital Biomarkers in Clinical […]

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, published in Nature, identifies a key marker of particularly aggressive and treatment-resistant colorectal cancer cells. At the same time, the researchers demonstrate using mini-tumors […]

Researchers at the German Cancer Research Center (DKFZ) have identified a previously unknown key mechanism by which cancer cells suppress the immune system and thus evade the effects of immunotherapies. At the same time, the new study in mouse models and human tumor samples points to a promising way to prevent resistance to immunotherapy. In […]

Primary CNS lymphomas in immunocompromised patients are among the rarest and at the same time most aggressive cancers – yet evidence-based recommendations for their diagnosis and treatment have been lacking. An international research team led by the Heidelberg Faculty of Medicine at Heidelberg University and the German Cancer Research Center has now identified characteristic imaging […]

The European Union is funding the PALACROS project with nearly €10 million under its “Horizon Europe” research programme. Researchers from Heidelberg University Hospital and Heidelberg University are helping shape the European PALACROS consortium, developing new standards for the treatment of locally advanced pancreatic cancer. PALACROS (Prioritising Multimodal Surgical Care for Patients with Locally Advanced Pancreatic […]